163 related articles for article (PubMed ID: 32622719)
1. Predictive power of Interleukin-28B gene variants for outcome of Hepatitis C Virus genotype 4 in Egyptians: A systematic review and meta-analysis.
El-Fattah MA
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101480. PubMed ID: 32622719
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
[TBL] [Abstract][Full Text] [Related]
3. IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.
Liu T; Sha K; Yang L; Wang Y; Zhang L; Liu X; Yang F
PLoS One; 2014; 9(3):e91316. PubMed ID: 24642705
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.
Riva E; Scagnolari C; Monteleone K; Selvaggi C; Picardi A; Mazzarelli C; Pizzigallo E; Vincenzi B; Carducci A; Antonaci S; Giannelli G; Antonelli G
J Viral Hepat; 2012 Sep; 19(9):650-3. PubMed ID: 22863269
[TBL] [Abstract][Full Text] [Related]
5. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
[TBL] [Abstract][Full Text] [Related]
6. Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis.
Li Y; Yang L; Sha K; Liu T; Zhang L
Int J Infect Dis; 2016 Dec; 53():52-58. PubMed ID: 27810523
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C in a Tunisian population.
Bizid S; Bouali R; Ouedrani A; Mrabet A; Ben Abdallah H; Ghazouani E; Abdelli N
Tunis Med; 2016 Jan; 94(1):6-11. PubMed ID: 27525598
[TBL] [Abstract][Full Text] [Related]
8. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR;
Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
10. The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.
Khubaib B; Saleem S; Idrees M; Afzal S; Wasim M
J Dig Dis; 2015 May; 16(5):293-8. PubMed ID: 25708904
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
Huang CF; Yeh ML; Hsieh MH; Hsieh MY; Lin ZY; Chen SC; Wang LY; Huang JF; Juo SH; Lin YC; Dai CY; Chuang WL; Yu ML
J Gastroenterol Hepatol; 2013 Sep; 28(9):1515-20. PubMed ID: 23560893
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.
De Nicola S; Aghemo A; Rumi MG; Galmozzi E; Valenti L; Soffredini R; De Francesco R; Prati GM; D'Ambrosio R; Cheroni C; Donato MF; Colombo M
Hepatology; 2012 Feb; 55(2):336-42. PubMed ID: 21932415
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response.
Abd El-Maksoud E; Salem AM; Maher AM; Hegazy MGA
Trop Biomed; 2020 Dec; 37(4):1083-1092. PubMed ID: 33612760
[TBL] [Abstract][Full Text] [Related]
15. Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.
Shaker O; Rashad A; Abd El Aziz G; El Raziky M
Cell Biochem Biophys; 2015 Jan; 71(1):307-14. PubMed ID: 25115611
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K
World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000
[TBL] [Abstract][Full Text] [Related]
17. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.
Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; García-Álvarez M; Resino S
BMC Med; 2013 Jan; 11():6. PubMed ID: 23298311
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
[TBL] [Abstract][Full Text] [Related]
20. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.
Kobayashi M; Suzuki F; Akuta N; Sezaki H; Suzuki Y; Hosaka T; Kawamura Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Chayama K; Miyakawa Y; Kumada H
J Gastroenterol; 2012 May; 47(5):596-605. PubMed ID: 22438096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
